The Archway Investment Fund annual report provides an overview of the fund's performance in 2016. The fund had a year-to-date return of 5.33%, slightly underperforming its benchmark, the S&P 500, which returned 5.88%. The healthcare sector significantly underperformed due to legal issues facing pharmaceutical companies. However, the consumer staples sector strongly outperformed, led by gains in Tyson Foods and General Mills. Overall, the fund is rebalancing its portfolio to better align with its target sector weights.